10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
In the realm of antibiotic research, the pursuit of new therapeutic avenues and the optimization of existing antibiotics are paramount. The evolution of resistance mechanisms in bacteria continually challenges the efficacy of antibiotics, necessitating innovative strategies to overcome this hurdle. Researchers are exploring various avenues such as combination therapies, antibiotic adjuvants, and bacteriophage therapy to enhance the effectiveness of antibiotics and prolong their lifespan. Moreover, efforts to discover new antibiotic classes with unique mechanisms of action are ongoing, fueled by advances in genomics, structural biology, and synthetic chemistry. Collaborative initiatives between academia, industry, and regulatory bodies are vital to accelerate the translation of promising research findings into clinical applications, ensuring that effective antibiotics remain a cornerstone of modern medicine for years to come.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States